This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Identification of predictive biomarkers of response for mTOR inhibitors in renal cell carcinoma: towards a molecular rationale for treatment selection in patients
Information
Date: 14/09/2020
Time 10:00
Venue: CNIO Auditorium
Conference Speaker Juan María Roldán
Institution Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme
Supervised by Cristina Rodríguez & Mercedes Robledo, Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme
Free admission until full capacity is reached